VECCHIO, VERONICA
VECCHIO, VERONICA
Università degli Studi di CATANIA
Complete Hematological Response Coupled with Molecular Response in Polycythemia Vera Treatment with Ropeginterferon alfa-2b
file da validare2026-01-01 Vecchio, Veronica; Cacciola, Rossella; Cacciola, Emma
Contributo delle piastrine reticolate alla generazione del fattore tessutale e del fattore di crescita trasformante-beta nella mielofibrosi primaria. Reticulated platelets contribution to tissue factor and transforming growth factor-beta generation in primary myelofibrosis.
file da validare2025-01-01 Vecchio, V.; Cacciola, R.; Cacciola, E.
Exploring the ABO haplotype and splanchnic thrombosis in patients with Primary Myelofibrosis
file da validare2025-01-01 Vecchio, Veronica; Cacciola, Rossella; Di Raimondo, Francesco; Duminuco, Andrea; Palumbo, Giuseppe A.; Cacciola, Emma
Molecular remission in the treatment of polycythemia vera: short-term effect of ropeginterferon alfa2-b
file da validare2026-01-01 Vecchio, Veronica; Cacciola, Rossella; Cacciola, Emma
Neutrophil-lymphocyte and platelet-lymphocyte ratios as predictors of atherosclerotic thrombotic risk in patients with myelofibrosis
2025-01-01 Vecchio, Veronica; Cacciola, Emma; Cacciola, Rossella
Primary myelofibrosis anf thrombotic risk: lower-riskIPSS vs higher-riskIPSS
file da validare2025-01-01 Vecchio, Veronica; Cacciola, Rossella; Cacciola, Emma
Rischio trombotico nei pazienti con mielofibrosi primaria: ruolo delle mutazioni JAK2/TET2 Thrombotic risk in patients with primary myelofibrosis: role of the JAK2/TET2 mutations
file da validare2026-01-01 Vecchio, Veronica; Cacciola, Rossella; Cacciola, Emma
Splanchnic vein thrombosis in JAK2V617F-positive patients with primary myelofibrosis and lower-risk IPSS.
file da validare2024-01-01 Cacciola, Rossella; Cacciola, Emma; Vecchio, Veronica
Thrombotic risk stratification in patients with prefibrotic myelofibrosis
file da validare2025-01-01 Vecchio, Veronica; Cacciola, Rossella; Cacciola, Emma